SURREY MEDICAL NETWORK LIMITEDActive

Company number 09402582Private limited companyIncorporated 2015

Key figures

£93,601+25.0%
Net assets 2024/25
+0.2%
Average annual growth 2020/21–2024/25
050 k100 k150 k2020/212021/222022/232023/242024/25

Like most small UK companies, SURREY MEDICAL NETWORK LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand520,546213,928119,23481,099127,465
Total assets800,275523,965———
Total liabilities707,535421,079———
Net assets / total equity92,740102,88651,68974,90793,601
Average number of employees33333

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity for the Company during the financial year was general medical practice activities.

As described in the company's latest filed accounts.

Summary: SURREY MEDICAL NETWORK LIMITED

Company

SURREY MEDICAL NETWORK LIMITED is a private limited company registered with Companies House under company number 09402582. It was incorporated on 22 Jan 2015. Its status is active. The registered office is in East molesey (KT8). Its nature of business (SIC 2007) is general medical practice activities (86210).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £93,601, up 25% on the previous year. Cash at bank and in hand was £127,465. The company had an average of 3 employees. Figures are available for 5 financial years (2020/21–2024/25).

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 5 Feb 2027.